$ 2,250.0
Quantity: 20 MG
In stock (can be backordered)
Description
Product name: MLN2238
Catalog#: 1601034
Synonyms: [(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid,
CAS NO.: 1072833-77-2
M.W: C14H19BCl2N2O4
M.F.: 361.03
Purity: 95% by HPLC
Format: Lyophilized powder
Description: MLN2238 is a potent proteasome inhibitor active in rituximab-chemotherapy-sensitive and rituximab-chemotherapy-resistant cell models and potentiates the antitumor activity of chemotherapy agents and has the potential of becoming an effective therapeutic agent in the treatment of therapy-resistant B-cell lymphoma.
Compound ID: 25183872
Usage: For Scientific Research Use Only, Not for Human Use.
